Synthesis of biguanides and an investigation of their therapeutic effects on brain tumours

Por Buttrus, Rita N, Haki, Kani, Eynon, Megan F, Smith, Ashleigh J S, Blazejczak, Natalia A, Pilkington, Geoffrey J, Nunn, Peter B, Higgins, Samantha C, Smith, James R
Publicado no Neuro Oncol (2018)

P07.01 18F-fluordesoxyglucose positron emission tomography (FDG-PET) for the detection of the primary lesion in brain metastasis (BM) patients with cancer of unknown primary site (CUPS)

Por Wolpert, F., Leske, H., Berghoff, A. S., Rushing, E. J., Andratschke, N., Regli, L., Stupp, R., Kaufmann, P., Preusser, M., Weller, M.
Publicado no Neuro Oncol (2016)

Brain metastasis from an unknown primary, or primary brain tumour? A diagnostic dilemma

Por Campos, S., Davey, P., Hird, A., Pressnail, B., Bilbao, J., Aviv, R.I., Symons, S., Pirouzmand, F., Sinclair, E., Culleton, S., DeSa, E., Goh, P., MBBS, E. Chow
Publicado em 2009

PNR-13 A CASE OF AN ADOLESCENT WITH BRAIN TUMOUR INADEQUATELY DIAGNOSED, TREATED AND REFERRED

Por Biassoni, Veronica, Schiavello, Elisabetta, Massimino, Maura
Publicado no Neuro Oncol (2016)

Treatment and outcome of patients with extragonadal germ cell tumours--the Norwegian Radium Hospital's experience 1979-94.

Por Dueland, S., Stenwig, A. E., Heilo, A., Høie, J., Ous, S., Fosså, S. D.
Publicado em 1998

Gonadal dysfunction after treatment of intracranial tumours.

Por Livesey, E A, Brook, C G
Publicado em 1988

ALA and ALA hexyl ester induction of porphyrins after their systemic administration to tumour bearing mice

Por Perotti, C, Casas, A, Fukuda, H, Sacca, P, Batlle, A
Publicado em 2002

P10.05 Periodic assessment with optical coherence tomography in children treated with multimodal therapies for brain tumors

Por Bacci, G. M., Ghin, M., Lucchesi, M., Guidi, M., Ferraro, M., Farina, S., Favre, C., Genitori, L., Caputo, R., Sardi, I.
Publicado no Neuro Oncol (2016)

The use and effectiveness of temozolomide in children with central nervous system tumours: a survey from the Canadian Paediatric Brain Tumour Consortium

Por Bartels, U., Baruchel, S., Carret, A.S., Crooks, B., Hukin, J., Johnston, D., Silva, M., Strother, D., Wilson, B., Zelcer, S., Eisenstat, D., Sung, L., Bouffet, E.
Publicado em 2011

Is cell survival a determinant of the in situ response of 9L tumours?

Por Wheeler, K. T., Wallen, C. A.
Publicado em 1980

Challenges to curing primary brain tumours

Por Aldape, Kenneth, Brindle, Kevin M., Chesler, Louis, Chopra, Rajesh, Gajjar, Amar, Gilbert, Mark R., Gottardo, Nicholas, Gutmann, David H., Hargrave, Darren, Holland, Eric C., Jones, David T. W., Joyce, Johanna A., Kearns, Pamela, Kieran, Mark W., Mellinghoff, Ingo K., Merchant, Melinda, Pfister, Stefan M., Pollard, Steven M., Ramaswamy, Vijay, Rich, Jeremy N., Robinson, Giles W., Rowitch, David H., Sampson, John H., Taylor, Michael D., Workman, Paul, Gilbertson, Richard J.
Publicado no Nat Rev Clin Oncol (2019)

SMART syndrome: a late reversible complication after radiation therapy for brain tumours

Por Kerklaan, Joost P., Lycklama á Nijeholt, Geert J., Wiggenraad, Ruud G. J., Berghuis, Bianca, Postma, Tjeerd J., Taphoorn, Martin J. B.
Publicado em 2011

PDTM-19. TUMOUR TREATING FIELDS (TTFIELDS) EXHIBIT EFFICACY ON HIGH-GRADE PAEDIATRIC BRAIN TUMOUR CELL LINES

Por Branter, Joshua, Estevez Cebrero, Maria de los Angeles, Grundy, Richard, Basu, Surajit, Smith, Stuart
Publicado no Neuro Oncol (2018)

Steroid hormones affect binding of the sigma ligand (11)C-SA4503 in tumour cells and tumour-bearing rats

Por Rybczynska, Anna A., Elsinga, Philip H., Sijbesma, Jurgen W., Ishiwata, Kiichi, de Jong, Johan R., de Vries, Erik F., Dierckx, Rudi A., van Waarde, Aren
Publicado em 2009

P05.53 Long-term cognitive function after radiation therapy for primary brain tumours grade I-III

Por Haldbo-Classen, L, Amidi, A, Lukacova, S, Wu, L, von Oettingen, G, Gottrup, H, Zachariae, R, Høyer, M
Publicado no Neuro Oncol (2018)

Tumour Treating Fields (TTFields) have anti-proliferative effects on paediatric brain tumour cell lines at clinically deliverable field settings

Por Branter, Joshua, de los Angeles Estevez-Cebrero, Maria, Grundy, Richard, Basu, Surajit, Smith, Stuart
Publicado no Neuro Oncol (2018)

Growth hormone and tumour recurrence.

Por Ogilvy-Stuart, A. L., Ryder, W. D., Gattamaneni, H. R., Clayton, P. E., Shalet, S. M.
Publicado em 1992

QOS-08 NEUROCOGNITIVE REHABILITATION IN CHILDREN TREATED FOR BRAIN TUMOURS: A PILOT STUDY IN GUSTAVE ROUSSY CANCER CAMPUS

Por Valès, Audrey Longaud, Lopez, Clémentine, Pouchepadass, Camille, Domer, Anne Laure, Dufour, Christelle, Couanet, Dominique Valteau
Publicado no Neuro Oncol (2016)

Imaging biomarkers of brain tumour margin and tumour invasion

Por Price, S J, Gillard, J H
Publicado em 2011

Phase II trial of temozolomide and reirradiation using conformal 3D-radiotherapy in recurrent brain gliomas

Por Osman, Mohammed A. M.
Publicado em 2014